Cite
HARVARD Citation
Ferrari, N. et al. (n.d.). The non-peptidomimetic cIAP1/2 and XIAP antagonist ASTX660 promotes an anti-tumour immune response in T-cell lymphoma. European journal of cancer. pp. S28-. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Ferrari, N. et al. (n.d.). The non-peptidomimetic cIAP1/2 and XIAP antagonist ASTX660 promotes an anti-tumour immune response in T-cell lymphoma. European journal of cancer. pp. S28-. [Online].